References
- Foye, M. O. Cancer Chemotherapeutic Agents; American ChemicalSociety: Washington, D.C., 1995; p 203.
- Liu, L. F.; Row, T. C.; Yang, L. J. Biol. Chem. 1984, 259,9182.
- Leopold, W. R.; Shillis, J. L.; Mertus, A. E.; Nelson, J. M.;Roberts, B. J.; Jackson, R. C. Cancer Res. 1984, 44, 1928.
- Scheithauer, W.; Von Hoff, D. D.; Clark, G. M.; Shillis, J. L.;Elslager, E. F. Eur. J. Cancer Clin. Oncol. 1986, 22, 921. https://doi.org/10.1016/0277-5379(86)90057-X
- Lown, J. W.; Sim, S. K.; Majumdar, K. C.; Chang, R. Y. Biochem. Biophys. Res. Commun. 1977, 76, 705. https://doi.org/10.1016/0006-291X(77)91557-1
- Tewey, K. M.; Chen, G. L.; Nelson, E. M.; Liu, L. F. J. Biol.Chem. 1984, 259, 9182.
- Hertzberg, R. P.; Dervan, P. B. Biochemistry 1984, 23, 3934. https://doi.org/10.1021/bi00312a022
- Silverman, R. B. The Organic Chemistry of Drug Design andDrug Action; Academic Press: New York, 1992; pp 255-258.
- Aviado, D. M.; Will, D. H. Am. J. Trop. Med. Hyg. 1969, 18,188.
- Skelton, F. S.; Bowman, C. M.; Porter, T. H.; Folkers, K.; Pardini,R. S. Biochem. Biophys. Res. Comm. 1971, 43, 102. https://doi.org/10.1016/S0006-291X(71)80092-X
- Kelker, V. V.; Dhumal, V. R.; Bhavsar, V. H.; Mardikar, B. R. Arch.Int. Pharmac. Ther. 1986, 283, 71.
- Rao, V. K.; McBrid, J. T.; Oleson, J. J. Cancer Res. 1968, 28,1952.
- Cho, H.; Chung, Y. Korean J. of Med. Chem. 1998, 8, 30.
- Benthey, W. H.; Robinson, R.; Weizmann, C. J. Chem. Soc.1907, 104.
- Carter, A. H.; Race, E.; Rowe, F. M. J. Chem. Soc.1942, 236. https://doi.org/10.1039/jr9420000236
- Zweig, A.; Maurer, A. H.; Roberts, B. G. J. Org.Chem. 1967, 32, 1332.
- Bacon, R. G. R.; Rennison, S. C. J.Chem. Soc. (C) 1969, 312. https://doi.org/10.1039/j19690000312
- Hansch, C.; Maloney, P. P.; Fujita,T.; Muir, R. M. Nature 1962, 194, 178.
- Lee, Y. S.; Lee, K. J.Bull. Korean Chem. Soc. 2002, 23, 1845. https://doi.org/10.5012/bkcs.2002.23.12.1845
- Carmichael, J.; DeGraff, W. G.; Gazdr, A. F.; Minna, J. D.;Mitchelle, J. B. Cancer Res. 1987, 47, 936.
- You, Y. J.; Ahn, B. Z. Arch. Pharm. Res. 1998, 21, 738. https://doi.org/10.1007/BF02976768
- You, Y. J.; Xheng, X. G.; Kim, Y.; Ahn, B. Z. Arch. Pharm. Res.1998, 21, 595. https://doi.org/10.1007/BF02975381
- Song, G. Y.; Kim, Y.; Cho, H.; Ahn, B. Z. Arch.Pharm. Res. 2001, 24, 190. https://doi.org/10.1007/BF02978254
Cited by
- Effects of β-lapachone, a new anticancer candidate, on cytochrome P450-mediated drug metabolism vol.72, pp.3, 2013, https://doi.org/10.1007/s00280-013-2230-x
- Synthesis and Cytotoxicity of Anilinomethyl-1,4-naphthoquinones. vol.36, pp.9, 2005, https://doi.org/10.1002/chin.200509088
- 3-Arylamino and 3-Alkoxy-nor-β-lapachone Derivatives: Synthesis and Cytotoxicity against Cancer Cell Lines vol.53, pp.1, 2004, https://doi.org/10.1021/jm900865m